Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine
Clinical trial NCT01625689 · COMPLETED
Trial details
- NCT number
- NCT01625689
- Sponsor
- PATH Vaccine Solutions
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-02-01
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.